India's Natco Pharma up after Q4 profit rise
** Shares of India's Natco Pharma NATP.NS up 2.5% after a
near 7% jump earlier in the session
** Drugmaker's Q4 consol net profit climbed 40% y/y while
rev rose ~19% y/y
** Trading vols 5.7x 30-day avg
** YTD, NATP has gained ~30% after climbing more than 44% in
2023
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees